Pharmaceutical Ingredients
Home / Products / 
What we are
We are the leading manufacturer & exporter of a broad ranger of pharmaceutical intermediates which are extensively used in various pharmaceutical companies & research laboratories. Using high quality chemicals these intermediates are manufactured which ensure efficacy and no side effect on human health. We offer standard as well as customized packaging on these products to exactly meet the users requirements specifications.
Intermediate List
| Intermediate Name | Code | CAS NO | API/ END USE |
|---|---|---|---|
| 5-((4-ethylpiperazine-1yl) methyl)pyridin-2amine./ USDMF No. 042443 | AMC-2 | 1180132-17-5 | Abemaciclib |
| 6-bromo-4-fluoro-1-isopropyl-2-methyl-1h-benzo[d]imidazole | AMA-2 | 1231930-33-8 |
|
| 4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole . USDMF : 042444 | AMA-3 | 1231930-37-2 |
|
| 6-(2-Chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole. | AMA-4 | 1231930-42-9 |
|
| 4-bromo-2,6-difluoroaniline | BDA-1 | 67567-26-4 |
|
| 6-bromonicotinaldehyde | BNA-2 | 149806-06-4 |
|
| Methyl 4-fluoro-3-hydroxybenzoate | ACR-1 | 214822-96-5 | Acoramidis |
| methyl 3-(3-bromopropoxy)-4-fluorobenzoate | ACR-2 | 1446701-52-5 |
|
| methyl 3-(3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoate | ARD2 | 1446701-54-7 |
|
| 3-(3-hydroxypropyl)pentane-2,4-dione | ACB-1 | 86351-06-6 |
|
| 3-(3,5-dimethyl-1H-pyrazol-4-yl)propan-1-ol | ACB-2 | 1779428-05-5 |
|
| 4-(3-chloropropyl)-3,5-dimethyl-1H-pyrazole hydrochloric acid | ARD-1 | 160979-71-5 |
|
| N,N-Dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate | DPPO-3 | 107688-86-8 | Atomoxetine |
| (R)-3-Amino-piperidine dihydrochloride | CNOP-6 | 334618-23-4 | Alogliptin Linagliptin |
| (R)-3-(Boc-Amino)piperidine | BCN-4 | 309956-78-3 |
|
| Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl)butanoate | DAM-3 | 3543-72-4 | Bendamustine |
| Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate | DAM-4 | 3543-73-5 |
|
| 2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone | CGF-3 | 32384-65-9 | Canagliflozin Dapagliflozin Empagliflozin |
| 4-chloro-6,7-dimethoxyquinoline | CAB-4 | 35654-56-9 | Cabozantinib |
| 4- Guanidinobenzoic Acid HCl | GBA HCl | 42823-46-1 | Camostat mesylate |
| 2-Chloro-N,N-dimethylacetamide | CST-1 | 2675-89-0 |
|
| 4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester | CST-2 | 59721-16-3 |
|
| 3-(3-Trifluoromethylphenyl)propionic Acid | TPA-2 | 585-50-2 | Cinacalcet |
| (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-trifluoromethyl) phenyl)propanamide | CNC | 1005450-55-4 | |
| 4-(4-Chlorophenyl)-1H-benzo[D][1,2]oxazin-1-one | CLT-1 | 2224-83-1 | Chlorthalidone |
| 3-(4'-chlorophenyl) phthalimidine | CLT-2 | 2224-77-3 |
|
| N-(2-Hydroxyethyl) succinimide | HDS-1 | 18190-44-8 | Diroximel |
| (E)-4-(2-(2,5-dioxopyrrolidin-1-yl)ethoxy)-4-oxobut-2-enoic acid | HDS-2 | 429659-01-8 |
|
| Ethyl 3(-4-(ethyl amino)-3- nitro-N-(pyridin-2-yl)benzamido) propanoate | DG-2 | 1307233-94-8 | Dabigatran |
| Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate | CBA-3G | 212322-56-0 |
|
| 2-(4-Cyanophenylamino) Acetic Acid | CBA-4 | 42288-26-6 |
|
| Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl]carbonyl]pyridine-2-ylamino] propionate. | DBG-1 | 211915-84-3 |
|
| Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride. | DBG-2 | 211914-50-0 |
|
| ethyl 3-[[2-(chloromethyl)-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate | DAB-1 | 1307233-94-8 |
|
| Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl) phenyl) amino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propanoate | DAB-2 | 211915-06-9 |
|
| Hexyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NAR-2 | 1307233-93-7 |
|
| 2-(N-BOC)-Aminothiazole-5-carboxylic acid | DTB-3 | 302964-02-9 | Dasatinib |
| (E)-N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide | ATC-2 | 863127-76-8 |
|
| 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | ATC-3 | 302964-24-5 |
|
| 4,6-dichloro-2-methylpyrimidine | PMD-2 | 1780-26-3 |
|
| Methyl 5-(tert-butyl)-2-hydroxybenzoate | DTH1 | 52888-72-9 | Deutivacraftor |
| N-Boc-D-phenyl glycinol | RPG-2 | 102089-74-7 | Elagolix |
| (R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate | RPG-3 | 102089-75-8 | |
| 1,3-dimethyl-1H-pyrazole-4-sulfonamide | DPS2 | 88398-53-2 | Elexacaftor |
| 2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde | DBD | 29668-44-8 | Eliglustat |
| (S)-(+)-2-Phenylglycinol | ELG | 20989-17-7 |
|
| 6,7-Dihydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin-4-one ( USDMF No. 40783) | ENS-2 | 76536-66-8 | Ensifentrine |
| N-(2-bromoethyl)phthalimide | ENB | 574-98-1 |
|
| (E)-2-(2-(2-(Mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)isoindoline-1,3-dione | ENS-3 | 3046226-90-5 |
|
| (E)-3-(2-Aminoethyl)-2-(mesitylimino)-9,10-dimethoxy-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one | ENS-4 | 3046226-91-6 |
|
| 4-(chloromethyl)-1-cyclopentyl 2-(trifluoromethyl)benzene | CCB2 | 957208-65-0 | Etrasimod |
| (7-hydroxy-1,2,3,4-tetrahydro cyclopenta[b]indol-3-yl) acetic acid | ETC2 | 1643842-61-8 |
|
| ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate | ETC3 | 1206124-13-1 |
|
| Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydro Product Name : cyclopenta[b]indol-3-yl)acetate. USDFM No. 043543 | ETC4 | 1206124-34-6 |
|
| 3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IBT-4 | 151266-23-8 | Futibatinib |
| 3-(N-Methyl-N-Pentyl amino)propionic acid HCl | IBA3 | 625120-81-2 | Ibandronate |
| 4-Aminopyrazolo[3,4-d]pyrimidine | IBT-3P | 2380-63-4 | Ibrutinib |
| 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | PPA-2 | 330786-24-8 |
|
| (ethane-1,2-diylbis(oxy)) bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) | ICT-1 | 19249-03-7 | Icotinib |
| 4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride | MPB-2 | 106261-49-8 | Imatinib |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | IMA-5 | 152460-10-1 |
|
| Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate | IVF-2 | 52980-28-6 | Ivacaftor |
| 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (USDMF No. 35586) | IVF-3P | 13721-01-2 |
|
| 5-Amino-2,4-ditert-butylphenol | ABN2 | 873055-58-4 |
|
| 2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate | TBC-2 | 873055-55-1 |
|
| 2,4-di-tert-butyl-5-nitro-phenol | TBC-3 | 873055-57-3 |
|
| 4-(chloroacetyl)-morpholine | CME | 1440-61-5 | Lesinurad |
| 4-Chloro-1-(4-fluorophenyl)butan-1-one | LMT-1 | 3874-54-2 | Lumateperone |
| 2-(2-Aminothiazol-4-yl)acetic acid | ATA-2 | 29676-71-9 | Mirabegron |
| 2-(2-Aminothiazol-4-yl)acetic acid hydrochloride | ATA-2 HCL | 66659-20-9 |
|
| 2-(4-nitrophenyl)ethanamine hydrochloride | MRG-2 | 29968-78-3 |
|
| (R)-2-(4-nitrophenethylamino)-1- Phenylethanol (USDMF No 35841 ) | MRG-4 BASE | 223673-34-5 |
|
| (R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride | MRG-4 | 521284-21-9 |
|
| (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | MRG-5 BASE | 391901-45-4 |
|
| (R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride | MRG-5 | 521284-22-0 |
|
| Etyl-3-guanidino-4-methyl-benzoate nitrate | NTB-4 | 641569-96-2 | Nilotinib |
| 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline | NTA-2 | 641571-11-1 |
|
| 3-dimethylamino-1-(3-pyridyl)-2-propen-1-one | IMA-3 | 55314-16-4 |
|
| 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid | NTC2 | 641569-94-0 |
|
| 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one | MCZ | 27387-31-1 | Ondansetron |
| 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one HCl | MAN | 119812-29-2 |
|
| 1,4-bis(bromomethyl)benzene | PRF-1 | 623-24-5 | Plerixafor |
| L-Glutamic acid diethyl ester hydrochloride | GDE | 1118-89-4 | Pemetrexed |
| 2-((4-Bromophenyl)(hydroxy)methylene)malononitrile | BMP1 | 1502821-65-9 | Pirtobrutinib |
| 2-[(4-Bromophenyl)methoxymethylene]propanedinitrile | BMP2 | 1188083-45-5 |
|
| 4-(6-Fluoro-1,2-benzisoxazole-3yl)-Piperidine Hydrochloride | PRSI-4 | 84163-13-3 | "Paliperidone/ Risperidone" |
| 4-[2,4-Difluoro benzoyl]Piperidine hydrochloride | PLP-2H | 106266-04-0 |
|
| 3-(Benzyloxy)pyridine-2-amine | POL-1 | 24016-03-3 |
|
| 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrididine-4-one | SPR2Base | 63234-80-0 |
|
| 2-Benzyl acrylic acid | RAC-2 | 5669-19-2 | Racecadotril |
| Benzyl glycinate p-toluene sulfonate | RAC-3 | 1738-76-7 |
|
| 3-Amino-6-methoxy pyridazine | AMP-2 | 7252-84-8 | Relugolix |
| Isonipecotamide /4-Piperidinecarboxamide | INA | 39546-32-2 | Revefenacin |
| 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide. USDMF No.043544 | RCP-3 | 1211443-61-6 | Ribociclib |
| Phenyl phenylcarbamate | RPT-1 | 4930-03-4 |
|
| (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione | RXD-1 | 446292-07-5 | Rivaroxaban |
| (S)-2-((2-oxo-3-(4-(3-oxomorpholino) phenyl) oxazolidin-5-yl) methyl)isoindoline-1,3-dione | RXD-2 | 446292-08-6 |
|
| (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl) morpholin-3-one hydrochloride | RXD-3 | 898543-06-1 |
|
| O-(1,1-Dimethylethyl)-N-(3-pyridinylcarbonyl) -L-Serine-1,1-dimethylethyl ester | SOD-1 | 2229891-12-5 | Serdexmethylphenidate |
| 4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | SITA2 | 764667-65-4 | Sitagliptin |
| 3-Quinuclidinone hydrochloride | RCN2 | 1193-65-3 | Solifenacin |
| 4-[2-hydroxyethyl]phenol | TRS-2 | 501-94-0 | Tyrosol |
| 4-chloro-7H-pyrrolo [2,3-d]pyrimidine | PPC-2 | 3680-69-1 | Tofacitinib Barcitinib Ruxolitinib |
| 4-bromo-7H pyrrolo[2,3D]pyrimidine | ITB-3 | 889939-42-8 |
|
| 2,4-Dichloro-1H-pyrrolo[2,3-D]pyrimidine | TDC | 90213-66-4 |
|
| 3-Cyclopentylacrylonitrile | CPA | 591769-05-0 |
|
| Bromoacetaldehyde Diethyl Acetal | DEDA | 2032-35-1 |
|
| 2-Bromo-1,1-dimethoxyethane | DMDA | 7252-83-7 |
|
| Formamidine acetate | FOA | 3473-63-0 |
|
| 1,4,7-Trimethyl-1,4,7-Triazacyclononane | TMT4 | 96556-05-7 | Others |
| BOC-L-Glutamine | NBG | 13726-85-7 |
|
| N-Boc-L-glutamic acid 1,5-dimethyl ester | BGM-2 | 59279-60-6 |
|
| 1-Methylpiperidine-4-carboxamide | MPC-2 | 62718-28-9 |
|
| 1-methylpiperidine-4-carbonitrile | MPC-3 | 20691-92-3 |
|
| (1-Methylpiperidin-4-Yl)Methanamine | MPC-4 | 7149-42-0 |
|
| Pipeline/ New Development | |||
| Intermediate Name | Code | CAS NO | API/ END USE |
| 3,6-dichloro-4-isopropylpyridazine | RSM-1 | 107228-51-3 | Resmetirom |
| 3,5-dichloro-4-((6-chloro-5-isopropylpyridazin-3-yl)oxy)aniline | RSM-2 | 920509-27-9 | |
| 6-chloro-4-isopropylpyridazin-3-(2H)-one | RSR-1 | 1696366-11-6 | |
| 6-(4-amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one | RSR-2 | 920509-28-0 | |
| ethyl (E)-(2-cyano-2-(2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-l)oxy)phenyl)hydrazineylidene)acetyl)carbamate | RSR-3 | 920509-33-7 | |
| Ethyl (2-cyanoacetyl)carbamate | RSA-1 | 6629-4-5. | |
| ethyl (E)-(2-cyano-2-(2-(3,5-dichloro-4-hydroxyphenyl) hydrazineylidene) acetyl)carbamate | RSC-1 | 2542038-33-3 | |
| 2-(3,5-dichloro-4-hydroxyphenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile | RSC-2 | 125001-18-5 | |
| Methyl 3,5-dimethoxybenzoate | DMB | 2150-37-0 | Tapinarof |
| Diethyl Benzylphosphonate | DBP | 1080-32-6 | |
| 2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropanoic acid | BTM-5 | 289686-70-0 | Elinzanetant/ Netupitant |
| 6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide | 342417-01-0 | Netupitant | |
| 2-(3,5-bis(trifluoromethyl)phenyl)-N-(6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-yl)-N,2-dimethylpropanamide | 825643-73-0 | Elinzanetant | |
| (2R,4S)-4-Amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester | 261947-64-2 | Obicetrapib |
|
| tert-butyl 4-((2-chloropyrimidin-5-yl)oxy)butanoate | 995771-55-1 | ||
| 1-Bromo-3,5-bis(trifluoro methyl) benzaldehyde | 401-95-6 | ||
| 2-(thiophen-2-yl)acetic acid | THA-1 | 1918-77-0 | Others |
| 1-bromo-4-phenoxybenzene | BPB-1 | 101-55-3 | Others |
| 2-((tert-butoxycarbonyl) (ethyl) amino) acetic acid | BNG-2 | 149794-10-5 | Others |
| 5-Norbornene-2-carboxylic Acid | NCA-1 | 120-74-1 | Others |
| (S)-2-Morpholin-4-yl-propionic acid hydrochloride | MPP-3 | 237427-96-2 | |
Note: All Transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third parties’ patent rights in a specific country lies exclusively with the buyer
Intermediate List
| Intermediate Name | Code | CAS NO | API/ END USE |
|---|---|---|---|
| 5-((4-ethylpiperazine-1yl) methyl)pyridin-2amine./ USDMF No. 042443 | AMC-2 | 1180132-17-5 | Abemaciclib |
| 6-bromo-4-fluoro-1-isopropyl-2-methyl-1h-benzo[d]imidazole | AMA-2 | 1231930-33-8 |
|
| 4-fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole . USDMF : 042444 | AMA-3 | 1231930-37-2 |
|
| 6-(2-Chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole. | AMA-4 | 1231930-42-9 |
|
| 4-bromo-2,6-difluoroaniline | BDA-1 | 67567-26-4 |
|
| 6-bromonicotinaldehyde | BNA-2 | 149806-06-4 |
|
| Methyl 4-fluoro-3-hydroxybenzoate | ACR-1 | 214822-96-5 | Acoramidis |
| methyl 3-(3-bromopropoxy)-4-fluorobenzoate | ACR-2 | 1446701-52-5 |
|
| methyl 3-(3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoate | ARD2 | 1446701-54-7 |
|
| 3-(3-hydroxypropyl)pentane-2,4-dione | ACB-1 | 86351-06-6 |
|
| 3-(3,5-dimethyl-1H-pyrazol-4-yl)propan-1-ol | ACB-2 | 1779428-05-5 |
|
| 4-(3-chloropropyl)-3,5-dimethyl-1H-pyrazole hydrochloric acid | ARD-1 | 160979-71-5 |
|
| N,N-Dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate | DPPO-3 | 107688-86-8 | Atomoxetine |
| (R)-3-Amino-piperidine dihydrochloride | CNOP-6 | 334618-23-4 | Alogliptin Linagliptin |
| (R)-3-(Boc-Amino)piperidine | BCN-4 | 309956-78-3 |
|
| Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl)butanoate | DAM-3 | 3543-72-4 | Bendamustine |
| Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate | DAM-4 | 3543-73-5 |
|
| 2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone | CGF-3 | 32384-65-9 | Canagliflozin Dapagliflozin Empagliflozin |
| 4-chloro-6,7-dimethoxyquinoline | CAB-4 | 35654-56-9 | Cabozantinib |
| 4- Guanidinobenzoic Acid HCl | GBA HCl | 42823-46-1 | Camostat mesylate |
| 2-Chloro-N,N-dimethylacetamide | CST-1 | 2675-89-0 |
|
| 4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester | CST-2 | 59721-16-3 |
|
| 3-(3-Trifluoromethylphenyl)propionic Acid | TPA-2 | 585-50-2 | Cinacalcet |
| (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-trifluoromethyl) phenyl)propanamide | CNC | 1005450-55-4 | |
| 4-(4-Chlorophenyl)-1H-benzo[D][1,2]oxazin-1-one | CLT-1 | 2224-83-1 | Chlorthalidone |
| 3-(4'-chlorophenyl) phthalimidine | CLT-2 | 2224-77-3 |
|
| N-(2-Hydroxyethyl) succinimide | HDS-1 | 18190-44-8 | Diroximel |
| (E)-4-(2-(2,5-dioxopyrrolidin-1-yl)ethoxy)-4-oxobut-2-enoic acid | HDS-2 | 429659-01-8 |
|
| Ethyl 3(-4-(ethyl amino)-3- nitro-N-(pyridin-2-yl)benzamido) propanoate | DG-2 | 1307233-94-8 | Dabigatran |
| Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate | CBA-3G | 212322-56-0 |
|
| 2-(4-Cyanophenylamino) Acetic Acid | CBA-4 | 42288-26-6 |
|
| Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl]carbonyl]pyridine-2-ylamino] propionate. | DBG-1 | 211915-84-3 |
|
| Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride. | DBG-2 | 211914-50-0 |
|
| ethyl 3-[[2-(chloromethyl)-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate | DAB-1 | 1307233-94-8 |
|
| Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl) phenyl) amino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propanoate | DAB-2 | 211915-06-9 |
|
| Hexyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NAR-2 | 1307233-93-7 |
|
| 2-(N-BOC)-Aminothiazole-5-carboxylic acid | DTB-3 | 302964-02-9 | Dasatinib |
| (E)-N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide | ATC-2 | 863127-76-8 |
|
| 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | ATC-3 | 302964-24-5 |
|
| 4,6-dichloro-2-methylpyrimidine | PMD-2 | 1780-26-3 |
|
| Methyl 5-(tert-butyl)-2-hydroxybenzoate | DTH1 | 52888-72-9 | Deutivacraftor |
| N-Boc-D-phenyl glycinol | RPG-2 | 102089-74-7 | Elagolix |
| (R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate | RPG-3 | 102089-75-8 | |
| 1,3-dimethyl-1H-pyrazole-4-sulfonamide | DPS2 | 88398-53-2 | Elexacaftor |
| 2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde | DBD | 29668-44-8 | Eliglustat |
| (S)-(+)-2-Phenylglycinol | ELG | 20989-17-7 |
|
| 6,7-Dihydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin-4-one ( USDMF No. 40783) | ENS-2 | 76536-66-8 | Ensifentrine |
| N-(2-bromoethyl)phthalimide | ENB | 574-98-1 |
|
| (E)-2-(2-(2-(Mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)isoindoline-1,3-dione | ENS-3 | 3046226-90-5 |
|
| (E)-3-(2-Aminoethyl)-2-(mesitylimino)-9,10-dimethoxy-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one | ENS-4 | 3046226-91-6 |
|
| 4-(chloromethyl)-1-cyclopentyl 2-(trifluoromethyl)benzene | CCB2 | 957208-65-0 | Etrasimod |
| (7-hydroxy-1,2,3,4-tetrahydro cyclopenta[b]indol-3-yl) acetic acid | ETC2 | 1643842-61-8 |
|
| ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate | ETC3 | 1206124-13-1 |
|
| Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydro Product Name : cyclopenta[b]indol-3-yl)acetate. USDFM No. 043543 | ETC4 | 1206124-34-6 |
|
| 3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IBT-4 | 151266-23-8 | Futibatinib |
| 3-(N-Methyl-N-Pentyl amino)propionic acid HCl | IBA3 | 625120-81-2 | Ibandronate |
| 4-Aminopyrazolo[3,4-d]pyrimidine | IBT-3P | 2380-63-4 | Ibrutinib |
| 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | PPA-2 | 330786-24-8 |
|
| (ethane-1,2-diylbis(oxy)) bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) | ICT-1 | 19249-03-7 | Icotinib |
| 4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride | MPB-2 | 106261-49-8 | Imatinib |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | IMA-5 | 152460-10-1 |
|
| Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate | IVF-2 | 52980-28-6 | Ivacaftor |
| 4-oxo-1,4-dihydroquinoline-3-carboxylic acid (USDMF No. 35586) | IVF-3P | 13721-01-2 |
|
| 5-Amino-2,4-ditert-butylphenol | ABN2 | 873055-58-4 |
|
| 2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate | TBC-2 | 873055-55-1 |
|
| 2,4-di-tert-butyl-5-nitro-phenol | TBC-3 | 873055-57-3 |
|
| 4-(chloroacetyl)-morpholine | CME | 1440-61-5 | Lesinurad |
| 4-Chloro-1-(4-fluorophenyl)butan-1-one | LMT-1 | 3874-54-2 | Lumateperone |
| 2-(2-Aminothiazol-4-yl)acetic acid | ATA-2 | 29676-71-9 | Mirabegron |
| 2-(2-Aminothiazol-4-yl)acetic acid hydrochloride | ATA-2 HCL | 66659-20-9 |
|
| 2-(4-nitrophenyl)ethanamine hydrochloride | MRG-2 | 29968-78-3 |
|
| (R)-2-(4-nitrophenethylamino)-1- Phenylethanol (USDMF No 35841 ) | MRG-4 BASE | 223673-34-5 |
|
| (R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride | MRG-4 | 521284-21-9 |
|
| (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | MRG-5 BASE | 391901-45-4 |
|
| (R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride | MRG-5 | 521284-22-0 |
|
| Etyl-3-guanidino-4-methyl-benzoate nitrate | NTB-4 | 641569-96-2 | Nilotinib |
| 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline | NTA-2 | 641571-11-1 |
|
| 3-dimethylamino-1-(3-pyridyl)-2-propen-1-one | IMA-3 | 55314-16-4 |
|
| 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid | NTC2 | 641569-94-0 |
|
| 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one | MCZ | 27387-31-1 | Ondansetron |
| 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one HCl | MAN | 119812-29-2 |
|
| 1,4-bis(bromomethyl)benzene | PRF-1 | 623-24-5 | Plerixafor |
| L-Glutamic acid diethyl ester hydrochloride | GDE | 1118-89-4 | Pemetrexed |
| 2-((4-Bromophenyl)(hydroxy)methylene)malononitrile | BMP1 | 1502821-65-9 | Pirtobrutinib |
| 2-[(4-Bromophenyl)methoxymethylene]propanedinitrile | BMP2 | 1188083-45-5 |
|
| 4-(6-Fluoro-1,2-benzisoxazole-3yl)-Piperidine Hydrochloride | PRSI-4 | 84163-13-3 | "Paliperidone/ Risperidone" |
| 4-[2,4-Difluoro benzoyl]Piperidine hydrochloride | PLP-2H | 106266-04-0 |
|
| 3-(Benzyloxy)pyridine-2-amine | POL-1 | 24016-03-3 |
|
| 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrididine-4-one | SPR2Base | 63234-80-0 |
|
| 2-Benzyl acrylic acid | RAC-2 | 5669-19-2 | Racecadotril |
| Benzyl glycinate p-toluene sulfonate | RAC-3 | 1738-76-7 |
|
| 3-Amino-6-methoxy pyridazine | AMP-2 | 7252-84-8 | Relugolix |
| Isonipecotamide /4-Piperidinecarboxamide | INA | 39546-32-2 | Revefenacin |
| 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide. USDMF No.043544 | RCP-3 | 1211443-61-6 | Ribociclib |
| Phenyl phenylcarbamate | RPT-1 | 4930-03-4 |
|
| (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione | RXD-1 | 446292-07-5 | Rivaroxaban |
| (S)-2-((2-oxo-3-(4-(3-oxomorpholino) phenyl) oxazolidin-5-yl) methyl)isoindoline-1,3-dione | RXD-2 | 446292-08-6 |
|
| (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl) morpholin-3-one hydrochloride | RXD-3 | 898543-06-1 |
|
| O-(1,1-Dimethylethyl)-N-(3-pyridinylcarbonyl) -L-Serine-1,1-dimethylethyl ester | SOD-1 | 2229891-12-5 | Serdexmethylphenidate |
| 4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | SITA2 | 764667-65-4 | Sitagliptin |
| 3-Quinuclidinone hydrochloride | RCN2 | 1193-65-3 | Solifenacin |
| 4-[2-hydroxyethyl]phenol | TRS-2 | 501-94-0 | Tyrosol |
| 4-chloro-7H-pyrrolo [2,3-d]pyrimidine | PPC-2 | 3680-69-1 | Tofacitinib Barcitinib Ruxolitinib |
| 4-bromo-7H pyrrolo[2,3D]pyrimidine | ITB-3 | 889939-42-8 |
|
| 2,4-Dichloro-1H-pyrrolo[2,3-D]pyrimidine | TDC | 90213-66-4 |
|
| 3-Cyclopentylacrylonitrile | CPA | 591769-05-0 |
|
| Bromoacetaldehyde Diethyl Acetal | DEDA | 2032-35-1 |
|
| 2-Bromo-1,1-dimethoxyethane | DMDA | 7252-83-7 |
|
| Formamidine acetate | FOA | 3473-63-0 |
|
| 1,4,7-Trimethyl-1,4,7-Triazacyclononane | TMT4 | 96556-05-7 | Others |
| BOC-L-Glutamine | NBG | 13726-85-7 |
|
| N-Boc-L-glutamic acid 1,5-dimethyl ester | BGM-2 | 59279-60-6 |
|
| 1-Methylpiperidine-4-carboxamide | MPC-2 | 62718-28-9 |
|
| 1-methylpiperidine-4-carbonitrile | MPC-3 | 20691-92-3 |
|
| (1-Methylpiperidin-4-Yl)Methanamine | MPC-4 | 7149-42-0 |
|
| Pipeline/ New Development | |||
| Intermediate Name | Code | CAS NO | API/ END USE |
| 3,6-dichloro-4-isopropylpyridazine | RSM-1 | 107228-51-3 | Resmetirom |
| 3,5-dichloro-4-((6-chloro-5-isopropylpyridazin-3-yl)oxy)aniline | RSM-2 | 920509-27-9 | |
| 6-chloro-4-isopropylpyridazin-3-(2H)-one | RSR-1 | 1696366-11-6 | |
| 6-(4-amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one | RSR-2 | 920509-28-0 | |
| ethyl (E)-(2-cyano-2-(2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-l)oxy)phenyl)hydrazineylidene)acetyl)carbamate | RSR-3 | 920509-33-7 | |
| Ethyl (2-cyanoacetyl)carbamate | RSA-1 | 6629-4-5. | |
| ethyl (E)-(2-cyano-2-(2-(3,5-dichloro-4-hydroxyphenyl) hydrazineylidene) acetyl)carbamate | RSC-1 | 2542038-33-3 | |
| 2-(3,5-dichloro-4-hydroxyphenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile | RSC-2 | 125001-18-5 | |
| Methyl 3,5-dimethoxybenzoate | DMB | 2150-37-0 | Tapinarof |
| Diethyl Benzylphosphonate | DBP | 1080-32-6 | |
| 2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropanoic acid | BTM-5 | 289686-70-0 | Elinzanetant/ Netupitant |
| 6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide | 342417-01-0 | Netupitant | |
| 2-(3,5-bis(trifluoromethyl)phenyl)-N-(6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-yl)-N,2-dimethylpropanamide | 825643-73-0 | Elinzanetant | |
| (2R,4S)-4-Amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester | 261947-64-2 | Obicetrapib |
|
| tert-butyl 4-((2-chloropyrimidin-5-yl)oxy)butanoate | 995771-55-1 | ||
| 1-Bromo-3,5-bis(trifluoro methyl) benzaldehyde | 401-95-6 | ||
| 2-(thiophen-2-yl)acetic acid | THA-1 | 1918-77-0 | Others |
| 1-bromo-4-phenoxybenzene | BPB-1 | 101-55-3 | Others |
| 2-((tert-butoxycarbonyl) (ethyl) amino) acetic acid | BNG-2 | 149794-10-5 | Others |
| 5-Norbornene-2-carboxylic Acid | NCA-1 | 120-74-1 | Others |
| (S)-2-Morpholin-4-yl-propionic acid hydrochloride | MPP-3 | 237427-96-2 | |
Note: All Transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third parties’ patent rights in a specific country lies exclusively with the buyer
